Association For Cannabis Health Equity and Medicine Resigns From US Cannabis Council

The Association for Cannabis Health and Medicine (ACHEM) is no longer aligned with the US Cannabis Council (USCC), a leading voice for ending the federal prohibition of cannabis.

In an open letter to USCC president and CEO Steven Hawkins on Aug. 17, ACHEM president Ogadinma Obie, M.D., informed USCC leadership that her association is resigning from its position on the USCC board of directors and general membership, effective immediately.

ACHEM is a professional medical association with the Cannabis Health Movement (CHEM). The mutual benefit nonprofit organization serves the needs of health and medical professionals in the advancement of health equity.

The association joined USCC as a founding member of its executive council in early 2021 and was encouraged by the organization’s commitment to make social a central focus in driving federal cannabis policy reform, Obie wrote in the open letter.

In USCC’s about statement, the organization claims to have become a leading force for “creating an equitable values-driven cannabis industry.”

Since joining USCC, Obie wrote that ACHEM’s leadership has “recognized the increasing influence of corporate cannabis priorities over the council that has continually overshadowed or siloed equity-focused recommendations.”

USCC’s membership does include some of the world’s largest cannabis operators and related companies in the industry, such as Curaleaf, Canopy Growth, Cronos Group, Cresco Labs, Columbia Care, Aurora Cannabis, Akerna, Ascend Wellness and others.

Obie added that USCC’s focus on short-term corporate and institution interests has hindered its ability to advance comprehensive and equitable

Association For Cannabis Health Equity and Medicine Resigns From US Cannabis Council on cannabis business times